Falciparum Malaria: Clinical Trials

7 trials for Falciparum Malaria, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 terminated, 1 unknown, 1 withdrawn. 7 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 17Completed 4, Terminated 1, Unknown 1, Withdrawn 1
Phase 21Completed 1

Follow Falciparum Malaria: new trials by email Literature Review of Falciparum Malaria trials Research Report on Falciparum Malaria

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Determine Safety, Tolerability, and Pharmacokinetics of Different Orally Administered Regimens of the Combination ZY19489-Ferroquine in Adult Asymptomatic Plasmodium Falciparum Carriers
ZY19489 + Ferroquine (FQ), Placebo - Uncomplicated Malaria, Asymptomatic Condition
Phase 1UnknownZydus Lifesciences Limited362024-08-302024-10-01
Nitrite Infusion in Children With Malaria
Sodium Nitrite - Falciparum Malaria
Phase 1WithdrawnDuke University2021-06-012021-03-16
Bioequivalence Study Comparing Artesunate Tablet To Arsuamoon® Tablets (Guilin-China) In Healthy Subjects
Artesunate (Test), Artesunate (Comparator) - Falciparum Malaria
Phase 1CompletedPfizer402009-06-012010-06-25
A Bioequivalence Study Comparing Amodiaquine Tablet (Pfizer) To Amodiaquine Tablets (Arsuamoon-Guilin China) In Healthy Subjects
Amodiaquine (Test), Amodiaquine (Comparator) - Falciparum Malaria
Phase 1CompletedPfizer382009-06-012010-04-21
Phase Ib Trial of Two Virosome Formulated Malaria Vaccine Components (PEV 301, PEV 302) in Tanzania
PEV 301& 302 in virosomes, Inflexal V (active comparator) - Falciparum Malaria
Phase 1CompletedSwiss Tropical & Public Health Institute502008-01-012013-03-15
Safety and Efficacy Study of Adjunctive Rosiglitazone in the Treatment of Uncomplicated Falciparum Malaria
Rosiglitazone, Placebo - Falciparum Malaria
Phase 1 / Phase 2CompletedMahidol University1402004-12-012015-04-13
Phase Ia Malaria Vaccine Trial of Two Virosome-Formulated Peptides
Virosome-formulated synthetic peptides (malaria vaccine) - Falciparum Malaria
Phase 1TerminatedSwiss Tropical & Public Health Institute462003-11-012006-11-16

Narrower conditions

Malaria, Falciparum (7)  ·  Malaria (4)  ·  Asymptomatic Diseases (1)  ·  Communicable Diseases (1)

Broader conditions

Infections (7)  ·  Mosquito-Borne Diseases (7)  ·  Parasitic Diseases (7)  ·  Protozoan Infections (7)  ·  Vector Borne Diseases (7)  ·  Malaria (3)  ·  Disease Attributes (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)

Interventions

Amodiaquine (1)  ·  Artesunate (1)  ·  Inflexal V (1)  ·  Malaria Vaccines (1)  ·  Rosiglitazone (1)  ·  Sodium Nitrite (1)  ·  Virosomes (1)  ·  ZY-19489 (1)  ·  ferroquine (1)

Sponsors

Pfizer (2)  ·  Swiss Tropical & Public Health Institute (2)  ·  Duke University (1)  ·  Mahidol University (1)  ·  Zydus Lifesciences Limited (1)

Countries

Singapore (2)  ·  Tanzania (2)  ·  Gabon (1)  ·  Thailand (1)

Top investigators

Blaise Genton, MD PhD (2)  ·  Dr. Deven Parmar, MD,FCP (1)  ·  Kevin C Kain, MD, FRCPC (1)

Results publications

PMID 17925866, PMID 18060072, PMID 19673614, PMID 21799810

NIH funding

R01HL130763 (1)